H.C. Wainwright lowered the firm’s price target on Tenaya Therapeutics (TNYA) to $5 from $18 and keeps a Buy rating on the shares following the Q4 results. The firm cites the company’s ...

Chardan lowered the firm’s price target on Tenaya Therapeutics (TNYA) to $9 from $18 and keeps a Buy rating on the shares. The firm’s updated model incorporates equity dilution from the March ...

March 10, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies ...

Comparatively, Tenaya Therapeutics has a beta of 2.83, meaning that its stock price is 183% more volatile than the S&P 500. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks ...

Explore Tenaya Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TNYA. US Futures Tumble As Traders Await Trump's Congress Address ...

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...

March 10, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

We may earn commission from links on this page, but we only recommend products we back.